115 related articles for article (PubMed ID: 35992907)
1. Two novel heterozygous truncating variants in
Song X; Xu W; Xiao M; Lu Y; Lan X; Tang X; Xu N; Yu G; Zhang H; Wu S
Front Neurosci; 2022; 16():956429. PubMed ID: 35992907
[TBL] [Abstract][Full Text] [Related]
2. De novo variants of NR4A2 are associated with neurodevelopmental disorder and epilepsy.
Singh S; Gupta A; Zech M; Sigafoos AN; Clark KJ; Dincer Y; Wagner M; Humberson JB; Green S; van Gassen K; Brandt T; Schnur RE; Millan F; Si Y; Mall V; Winkelmann J; Gavrilova RH; Klee EW; Engleman K; Safina NP; Slaugh R; Bryant EM; Tan WH; Granadillo J; Misra SN; Schaefer GB; Towner S; Brilstra EH; Koeleman BPC
Genet Med; 2020 Aug; 22(8):1413-1417. PubMed ID: 32366965
[TBL] [Abstract][Full Text] [Related]
3. Trio exome sequencing identified a novel de novo WASF1 missense variant leading to recurrent site substitution in a Chinese patient with developmental delay, microcephaly, and early-onset seizures: A mutational hotspot p.Trp161 and literature review.
Zhao A; Zhou R; Gu Q; Liu M; Zhang B; Huang J; Yang B; Yao R; Wang J; Lv H; Wang J; Shen Y; Wang H; Chen X
Clin Chim Acta; 2021 Dec; 523():10-18. PubMed ID: 34478686
[TBL] [Abstract][Full Text] [Related]
4. Novel truncating variant of MN1 penultimate exon identified in a Chinese patient with newly recognized MN1 C-terminal truncation syndrome: Case report and literature review.
Zhao A; Shu D; Zhang D; Yang B; Hong L; Wang A; Yao R; Wang J; Lv H; Wang J; Shen Y; Wang H; Gu Q
Int J Dev Neurosci; 2022 Feb; 82(1):96-103. PubMed ID: 34708882
[TBL] [Abstract][Full Text] [Related]
5. NR4A2 haploinsufficiency is associated with intellectual disability and autism spectrum disorder.
Lévy J; Grotto S; Mignot C; Maruani A; Delahaye-Duriez A; Benzacken B; Keren B; Haye D; Xavier J; Heulin M; Charles E; Verloes A; Dupont C; Pipiras E; Tabet AC
Clin Genet; 2018 Aug; 94(2):264-268. PubMed ID: 29770430
[TBL] [Abstract][Full Text] [Related]
6. Identification of two novel variants of the
Che F; Tie X; Lei H; Zhang X; Duan M; Zhang L; Yang Y
Front Mol Neurosci; 2022; 15():927357. PubMed ID: 36176959
[TBL] [Abstract][Full Text] [Related]
7. Identification and functional characterization of
Li B; Wang Y; Hou D; Song Z; Zhang L; Li N; Yang R; Sun P
Front Genet; 2023; 14():1270175. PubMed ID: 37928246
[No Abstract] [Full Text] [Related]
8. Novel Heterozygous Missense Variant in GRIA4 Gene Associated With Neurodevelopmental Disorder With or Without Seizures and Gait Abnormalities.
Wang H; Liu J; Li F; Teng Z; Liu M; Gu W
Front Genet; 2022; 13():859140. PubMed ID: 35518358
[No Abstract] [Full Text] [Related]
9. The extended clinical and genetic spectrum of
Lee S; Jang SS; Park S; Yoon JG; Kim SY; Lim BC; Chae JH
Front Pediatr; 2022; 10():960450. PubMed ID: 35935366
[TBL] [Abstract][Full Text] [Related]
10. Haploinsufficiency of NR4A2 is associated with a neurodevelopmental phenotype with prominent language impairment.
Reuter MS; Krumbiegel M; Schlüter G; Ekici AB; Reis A; Zweier C
Am J Med Genet A; 2017 Aug; 173(8):2231-2234. PubMed ID: 28544326
[TBL] [Abstract][Full Text] [Related]
11. Loss-of-Function Mutations in NR4A2 Cause Dopa-Responsive Dystonia Parkinsonism.
Wirth T; Mariani LL; Bergant G; Baulac M; Habert MO; Drouot N; Ollivier E; Hodžić A; Rudolf G; Nitschke P; Rudolf G; Chelly J; Tranchant C; Anheim M; Roze E
Mov Disord; 2020 May; 35(5):880-885. PubMed ID: 31922365
[TBL] [Abstract][Full Text] [Related]
12. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
[TBL] [Abstract][Full Text] [Related]
13. De Novo Variants in CNOT1, a Central Component of the CCR4-NOT Complex Involved in Gene Expression and RNA and Protein Stability, Cause Neurodevelopmental Delay.
Vissers LELM; Kalvakuri S; de Boer E; Geuer S; Oud M; van Outersterp I; Kwint M; Witmond M; Kersten S; Polla DL; Weijers D; Begtrup A; McWalter K; Ruiz A; Gabau E; Morton JEV; Griffith C; Weiss K; Gamble C; Bartley J; Vernon HJ; Brunet K; Ruivenkamp C; Kant SG; Kruszka P; Larson A; Afenjar A; Billette de Villemeur T; Nugent K; ; Raymond FL; Venselaar H; Demurger F; Soler-Alfonso C; Li D; Bhoj E; Hayes I; Hamilton NP; Ahmad A; Fisher R; van den Born M; Willems M; Sorlin A; Delanne J; Moutton S; Christophe P; Mau-Them FT; Vitobello A; Goel H; Massingham L; Phornphutkul C; Schwab J; Keren B; Charles P; Vreeburg M; De Simone L; Hoganson G; Iascone M; Milani D; Evenepoel L; Revencu N; Ward DI; Burns K; Krantz I; Raible SE; Murrell JR; Wood K; Cho MT; van Bokhoven H; Muenke M; Kleefstra T; Bodmer R; de Brouwer APM
Am J Hum Genet; 2020 Jul; 107(1):164-172. PubMed ID: 32553196
[TBL] [Abstract][Full Text] [Related]
14. Splicing Interruption by Intron Variants in
Zhang W; Ye F; Chen S; Peng J; Pang N; Yin F
Front Neurosci; 2022; 16():892768. PubMed ID: 35774559
[No Abstract] [Full Text] [Related]
15. Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy.
Kanani F; Titheradge H; Cooper N; Elmslie F; Lees MM; Juusola J; Pisani L; McKenna C; Mignot C; Valence S; Keren B; Lachlan K; ; Balasubramanian M
Am J Med Genet A; 2020 Apr; 182(4):713-720. PubMed ID: 31926053
[TBL] [Abstract][Full Text] [Related]
16. A
Lu G; Ma L; Xu P; Xian B; Wu L; Ding J; He X; Xia H; Ding W; Yang Z; Peng Q
Front Genet; 2022; 13():840577. PubMed ID: 35432459
[No Abstract] [Full Text] [Related]
17. Whole exome sequencing reveals de novo pathogenic variants in KAT6A as a cause of a neurodevelopmental disorder.
Millan F; Cho MT; Retterer K; Monaghan KG; Bai R; Vitazka P; Everman DB; Smith B; Angle B; Roberts V; Immken L; Nagakura H; DiFazio M; Sherr E; Haverfield E; Friedman B; Telegrafi A; Juusola J; Chung WK; Bale S
Am J Med Genet A; 2016 Jul; 170(7):1791-8. PubMed ID: 27133397
[TBL] [Abstract][Full Text] [Related]
18. Heterozygous variants that disturb the transcriptional repressor activity of FOXP4 cause a developmental disorder with speech/language delays and multiple congenital abnormalities.
Snijders Blok L; Vino A; den Hoed J; Underhill HR; Monteil D; Li H; Reynoso Santos FJ; Chung WK; Amaral MD; Schnur RE; Santiago-Sim T; Si Y; Brunner HG; Kleefstra T; Fisher SE
Genet Med; 2021 Mar; 23(3):534-542. PubMed ID: 33110267
[TBL] [Abstract][Full Text] [Related]
19. Neurodevelopmental disorder caused by a truncating de novo variant of IRF2BPL.
Qian XH; Liu XY; Zhu ZY; Wang SG; Song XX; Chen G; Wu JY; Tang HD; Cao L
Seizure; 2021 Jan; 84():47-52. PubMed ID: 33278788
[TBL] [Abstract][Full Text] [Related]
20. De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy.
Usmani MA; Ahmed ZM; Magini P; Pienkowski VM; Rasmussen KJ; Hernan R; Rasheed F; Hussain M; Shahzad M; Lanpher BC; Niu Z; Lim FY; Pippucci T; Ploski R; Kraus V; Matuszewska K; Palombo F; Kianmahd J; ; Martinez-Agosto JA; Lee H; Colao E; Motazacker MM; Brigatti KW; Puffenberger EG; Riazuddin SA; Gonzaga-Jauregui C; Chung WK; Wagner M; Schultz MJ; Seri M; Kievit AJA; Perrotti N; Wassink-Ruiter JSK; van Bokhoven H; Riazuddin S; Riazuddin S
Am J Hum Genet; 2021 Jul; 108(7):1330-1341. PubMed ID: 34102099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
